Cytori Therapeutics reported $8.35M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Baxter International BAX:US $ 3344M 157M
Cerus CERS:US $ 65.82M 11.05M
Cytori Therapeutics CYTX:US $ 8.35M 0.04M
Genocea Biosciences GNCA:US $ 14.83M 3.41M
Haemonetics HAE:US $ 228.34M 25.16M
Infinity Pharmaceuticals INFI:US $ 10.55M 1.1M
Merrimack Pharmaceuticals MACK:US $ 770K 1.45M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Northwest Biotherapeutics NWBO:US 360.71M 2.7M
Starpharma Holdings Ltd SPL:AU 10.43M 3.08M
Sunesis Pharmaceuticals SNSS:US $ 6.95M 0.69M
Teva Pharmaceutical TEVA:IT 11.82B 866M